$NTRP
NextTrip, Inc. Stock $ntrp

$ntrp Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000149315223017303 Filed on May 15, 2023

Income Statement

Concept	2023 Q2	2023 Q1	2022 Q1
Revenue	$97.04K	$130.2K	$51.84K
YoY Change	-58.99%	151.08%	-88.68%
Cost Of Revenue	$36.49K	$63.66K	$40.09K
YoY Change	-81.1%	58.8%	-68.76%
Gross Profit	$60.55K	$66.50K	$11.75K
YoY Change	38.93%	465.91%	-96.44%
Gross Profit Margin	62.4%	51.09%	22.67%
Selling, General & Admin	$938.9K	$1.495M	$1.880M
YoY Change	-47.85%	-20.46%	45.75%
% of Gross Profit	1550.55%	2248.56%	15998.55%
Research & Development	$105.3K	$126.7K	$143.4K
YoY Change	-28.34%	-11.65%	-26.95%
% of Gross Profit	173.83%	190.56%	1220.6%
Depreciation & Amortization	$21.47K	$28.13K	$31.58K
YoY Change	-28.1%	-10.93%	37.13%
% of Gross Profit	35.46%	42.3%	268.77%
Operating Expenses	$1.365M	$1.848M	$2.296M
YoY Change	-40.14%	-19.5%	28.87%
Operating Profit	-$1.304M	-$1.782M	-$2.284M
YoY Change	-41.68%	-21.99%	57.34%
Interest Expense	$3.235K	$3.235K	-$80.00
YoY Change	56.28%	-4143.75%	-100.01%
% of Operating Profit
Other Income/Expense, Net	-$4.075K	$29.95K	$76.63K
YoY Change	-64.03%	-60.92%
Pretax Income	-$1.308M	-$1.752M	-$2.207M
YoY Change	-41.79%	-20.64%	239.26%
Income Tax
% Of Pretax Income
Net Earnings	-$1.308M	-$1.752M	-$2.207M
YoY Change	-41.79%	-20.64%	239.26%
Net Earnings / Revenue	-1347.95%	-1345.81%	-4258.1%
Basic Earnings Per Share	-$0.12	-$0.17	-$0.21
Diluted Earnings Per Share	-$0.12	-$0.17	-$210.3K
COMMON SHARES
Basic Shares Outstanding	10.77M shares	10.77M shares	10.50M shares
Diluted Shares Outstanding	10.77M shares

Balance Sheet

Concept	2023 Q2	2023 Q1	2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$368.4K	$1.489M	$9.278M
YoY Change	-94.69%	-83.95%	-44.92%
Cash & Equivalents	$368.4K	$1.489M	$9.278M
Short-Term Investments
Other Short-Term Assets	$137.1K	$235.0K	$165.3K
YoY Change	4.28%	42.19%	22.02%
Inventory	$940.0K	$944.4K	$782.1K
Prepaid Expenses	$137.1K	$235.0K
Receivables	$45.45K	$210.4K	$261.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$1.491M	$2.879M	$10.49M
YoY Change	-81.68%	-72.55%	-42.11%
LONG-TERM ASSETS
Property, Plant & Equipment	$227.8K	$284.2K	$288.9K
YoY Change	-14.26%	-1.64%	125.16%
Goodwill
YoY Change
Intangibles	$1.215M	$1.166M
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.443M	$1.450M	$1.268M
YoY Change	11.44%	14.34%	38.31%
TOTAL ASSETS
Total Short-Term Assets	$1.491M	$2.879M	$10.49M
Total Long-Term Assets	$1.443M	$1.450M	$1.268M
Total Assets	$2.934M	$4.328M	$11.75M
YoY Change	-68.9%	-63.18%	-38.24%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$300.6K	$400.6K	$320.6K
YoY Change	25.03%	24.99%	14.3%
Accrued Expenses	$115.2K	$219.1K	$416.6K
YoY Change	-54.6%	-47.41%	91.65%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$542.9K	$773.2K	$897.5K
YoY Change	-13.11%	-13.85%	-83.62%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$0.00	$0.00	$0.00
YoY Change			-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$542.9K	$773.2K	$897.5K
Total Long-Term Liabilities	$0.00	$0.00	$0.00
Total Liabilities	$542.9K	$773.2K	$897.5K
YoY Change	-13.11%	-13.85%	-84.01%
SHAREHOLDERS EQUITY
Retained Earnings	-$52.52M	-$51.21M
YoY Change	16.52%
Common Stock	$10.77K	$10.77K
YoY Change	2.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.391M	$3.555M	$10.86M
YoY Change
Total Liabilities & Shareholders Equity	$2.934M	$4.328M	$11.75M
YoY Change	-68.9%	-63.18%	-38.24%

Cashflow Statement

Concept	2023 Q2	2023 Q1	2022 Q1
OPERATING ACTIVITIES
Net Income	-$1.308M	-$1.752M	-$2.207M
YoY Change	-41.79%	-20.64%	239.26%
Depreciation, Depletion And Amortization	$21.47K	$28.13K	$31.58K
YoY Change	-28.1%	-10.93%	37.13%
Cash From Operating Activities	-$1.105M	-$1.310M	-$2.027M
YoY Change	-51.68%	-35.4%	63.39%
INVESTING ACTIVITIES
Capital Expenditures	$57.43K		-$142.1K
YoY Change	-200.84%		546.79%
Acquisitions
YoY Change
Other Investing Activities	$42.52K
YoY Change
Cash From Investing Activities	-$14.92K	-$47.69K	-$142.1K
YoY Change	-73.8%	-66.44%	546.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000
YoY Change
NET CHANGE
Cash From Operating Activities	-1.105M	-$1.310M	-2.027M
Cash From Investing Activities	-14.92K	-$47.69K	-142.1K
Cash From Financing Activities	0.000
Net Change In Cash	-1.120M	-$1.357M	$0.00
YoY Change	-52.22%		-100.0%
FREE CASH FLOW
Cash From Operating Activities	-$1.105M	-$1.310M	-$2.027M
Capital Expenditures	$57.43K		-$142.1K
Free Cash Flow	-$1.163M	-$1.310M	-$1.885M
YoY Change	-47.87%	-30.53%	54.68%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0000788611
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	SASI	State Incentives StateIncentives		usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome		usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2023Q1	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
CY2022Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock		usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation		usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities		usd
CY2022Q1	SASI	Conversion Of Preferred Shares To Common Shares ConversionOfPreferredSharesToCommonShares		usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2023Q1	SASI	Operating Leases Future Minimum Payment Receivable In Three Years OperatingLeasesFutureMinimumPaymentReceivableInThreeYears		usd
CY2023Q1	SASI	Operating Leases Future Minimum Payment Receivable In Four Years OperatingLeasesFutureMinimumPaymentReceivableInFourYears		usd
CY2023Q1	SASI	Operating Leases Future Minimum Payment Receivable In Four Years And There After OperatingLeasesFutureMinimumPaymentReceivableInFourYearsAndThereAfter		usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted In Period Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedInPeriodIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2022	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Cancelled In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue		usd
CY2023Q1	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitedor Cancelled In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedorCancelledInPeriodTotalIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue		usd
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted		shares
CY2022	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Grants Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2022	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
CY2022	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Weighted Average Exercise Price Warrants Forfeited Or Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
CY2023Q1	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures		shares
CY2023Q1	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercised In Period Weighted Average Weighted Average Exercise Price Warrants Forfeited Or Cancelled ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageWeightedAverageExercisePriceWarrantsForfeitedOrCancelled
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-38015
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	SIGMA ADDITIVE SOLUTIONS, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1865814
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	3900 Paseo del Sol
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Santa Fe
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	NM
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	87507
CY2023Q1	dei	City Area Code CityAreaCode	(505)
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	438-2576
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, par value $0.001 per share
CY2023Q1	dei	Trading Symbol TradingSymbol	SASI
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10772713	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1488704	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2845931	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	210449	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	371620	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	944402	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	950943	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	235003	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	105226	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	2878558	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4273720	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	284193	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	304903	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1165558	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1125285	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	1449751	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	1430188	usd
CY2023Q1	us-gaap	Assets Assets	4328309	usd
CY2022Q4	us-gaap	Assets Assets	5703908	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	400640	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	277492	usd
CY2023Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	153443	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	120073	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	219126	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	231633	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	773209	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	629198	usd
CY2023Q1	us-gaap	Liabilities Liabilities	773209	usd
CY2022Q4	us-gaap	Liabilities Liabilities	629198	usd
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	316	shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	316	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	465	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	465	shares
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	1	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	24000000	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10772713	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10772713	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10498802	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10498802	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	10773	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	10499	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54749821	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54406694	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-51205495	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-49342484	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3555100	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5074710	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4328309	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5703908	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	130159	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51844	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	63664	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	40091	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	66495	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	11753	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	931583	usd
CY2022Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1292010	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	224850	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	170976	usd
CY2023Q1	SASI	Operations And Research And Development Expense OperationsAndResearchAndDevelopmentExpense	126712	usd
CY2022Q1	SASI	Operations And Research And Development Expense OperationsAndResearchAndDevelopmentExpense	143418	usd
CY2023Q1	SASI	Investor Public Relations InvestorPublicRelations	54944	usd
CY2022Q1	SASI	Investor Public Relations InvestorPublicRelations	94326	usd
CY2023Q1	SASI	Organizational Costs OrganizationalCosts	51198	usd
CY2022Q1	SASI	Organizational Costs OrganizationalCosts	58749	usd
CY2023Q1	us-gaap	Legal Fees LegalFees	184251	usd
CY2022Q1	us-gaap	Legal Fees LegalFees	211416	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	154499	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	205432	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28127	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31584	usd
CY2023Q1	us-gaap	Other Expenses OtherExpenses	91980	usd
CY2022Q1	us-gaap	Other Expenses OtherExpenses	87787	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	1848144	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2295698	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1781649	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-2283945	usd
CY2023Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	8	usd
CY2022Q1	us-gaap	Investment Income Interest InvestmentIncomeInterest	1571	usd
CY2022Q1	SASI	State Incentives StateIncentives	76628	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-2503	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-330	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	3235	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	1319	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	35680	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	29950	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	76550	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1751699	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2207395	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1751699	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2207395	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	11748	usd
CY2022Q1	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	14220	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1763447	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2221615	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10690677	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10498802	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	5074710	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1751699	usd
CY2023Q1	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	7728	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	489	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	224850	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	3555100	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	12859751	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2207395	usd
CY2022Q1	SASI	Adjustments To Additional Paid In Capital Stock Options Awarded To Directors For Services AdjustmentsToAdditionalPaidInCapitalStockOptionsAwardedToDirectorsForServices	21721	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	11713	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	170976	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	10856766	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1751699	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-2207395	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	28127	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31584	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-161171	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-151170	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-6541	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	72019	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	129777	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	50996	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	123148	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	114105	usd
CY2023Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	33370	usd
CY2022Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	11421	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-12507	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-209299	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1309537	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2027019	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	83248	usd
CY2023Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	47690	usd
CY2022Q1	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	58851	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-47690	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-142099	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1357227	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-2169118	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	2845931	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	11447047	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1488704	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	9277929	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	11748	usd
CY2022Q1	us-gaap	Stock Issued1 StockIssued1	14220	usd
CY2023Q1	SASI	Conversion Of Preferred Shares To Common Shares ConversionOfPreferredSharesToCommonShares	188830	usd
CY2023Q1	SASI	Issuance Of Securities For Services IssuanceOfSecuritiesForServices	7239	usd
CY2022Q1	SASI	Issuance Of Securities For Services IssuanceOfSecuritiesForServices	33434	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	3235	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	1319	usd
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7435402	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5522496	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.21
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1763447	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2221615	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10690677	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10498802	shares
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_847_eus-gaap--UseOfEstimates_zSSgXqFffNii" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zKZnA2xZorpj">Accounting Estimates</span></b> - The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain reported amounts of assets and liabilities, the disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimated by management. Significant accounting estimates that may materially change in the near future are impairment of long-lived assets, values of stock compensation awards and stock equivalents granted as offering costs, and allowance for bad debts and inventory obsolescence.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	17006	usd
CY2023Q1	SASI	Operating Leases Future Minimum Payment Receivable Next Twelve Months OperatingLeasesFutureMinimumPaymentReceivableNextTwelveMonths	28343	usd
CY2023Q1	SASI	Operating Leases Future Minimum Payment Receivable In Two Years OperatingLeasesFutureMinimumPaymentReceivableInTwoYears	8503	usd
CY2023Q1	SASI	Operating Leases Future Minimum Payment Receivable OperatingLeasesFutureMinimumPaymentReceivable	36846	usd
CY2023Q1	us-gaap	Property Subject To Or Available For Operating Lease Gross PropertySubjectToOrAvailableForOperatingLeaseGross	77208	usd
CY2023Q1	us-gaap	Property Subject To Or Available For Operating Lease Accumulated Depreciation PropertySubjectToOrAvailableForOperatingLeaseAccumulatedDepreciation	9688	usd
CY2023Q1	us-gaap	Property Subject To Or Available For Operating Lease Net PropertySubjectToOrAvailableForOperatingLeaseNet	67520	usd
CY2023Q1	us-gaap	Property Plant And Equipment Useful Life PropertyPlantAndEquipmentUsefulLife	P7Y
CY2023Q1	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	303219	usd
CY2022Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	294194	usd
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	212649	usd
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	140723	usd
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	428534	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	516026	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	944402	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	950943	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-82134	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-74716	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1165558	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1125285	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7418	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	4978	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	22404	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	29872	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	29872	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	29872	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	335726	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	447746	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	316	shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	316	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	465	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	465	shares
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	224850	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	170976	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.000	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0000	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0405	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum	0.0095	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum	0.0165	pure
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.002	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum	1.064	pure
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum	1.100	pure
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1395882	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.24
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y10M20D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	487473	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	2.50
CY2022	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P4Y5M4D
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	84302	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	4.39
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1799053	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.76
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y3M18D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	433665	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.58
CY2023Q1	SASI	Share Based Compensation Arrangement By Share Based Payment Award Options Granted Weighted Average Remaining Contractual Term ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantedWeightedAverageRemainingContractualTerm	P4Y9M29D
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	170059	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	3.04
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2062659	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.15
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y4M28D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	555378	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	1.99
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P4Y1M28D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1507281	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.58
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y1M20D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber	2062659	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.15
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P3Y4M28D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	0.44
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	581865	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y7M2D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3987931	shares
CY2021Q4	SASI	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	6.10
CY2021	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P2Y1M6D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures	164652	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	3823279	shares
CY2022Q4	SASI	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	4.66
CY2022	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P1Y2M8D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	1490896	shares
CY2023Q1	SASI	Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice	0.58
CY2023Q1	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Grants Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonGrantsWeightedAverageRemainingContractualTerm	P2Y10M13D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	5314175	shares
CY2023Q1	SASI	Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice	3.19
CY2023Q1	SASI	Sharebased Compensation Arrangement By Sharebased Payment Award Options Non Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonOutstandingWeightedAverageRemainingContractualTerm	P1Y5M23D

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
sasi-20230331_cal.xml	Edgar Link	unprocessable
0001493152-23-017303-index-headers.html	Edgar Link	pending
0001493152-23-017303-index.html	Edgar Link	pending
0001493152-23-017303.txt	Edgar Link	pending
0001493152-23-017303-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sasi-20230331.xsd	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending
sasi-20230331_lab.xml	Edgar Link	unprocessable
sasi-20230331_def.xml	Edgar Link	unprocessable
sasi-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NTRP
NextTrip, Inc. Stock $ntrp

2023 Q2 Form 10-Q Financial Statement

#000149315223017303 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTRP NextTrip, Inc. Stock $ntrp

2023 Q2 Form 10-Q Financial Statement

#000149315223017303 Filed on May 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NTRP
NextTrip, Inc. Stock $ntrp